DrugDashboards
← Home
Manufacturing facility

Gland Pharma Limited

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.

Country
India
Registered address
Plot no: 42-52, 54, 55, 64-68, Sy. No. 166, 171, 172 & 177, Phase III, TSIIC, Pashamylaram Village, Patancheru Mandal, Sangareddy District, Hyderabad, Telangana 502307, India (IND)
Operations here
analysislabelmanufacturepack
FDA identifiers
FEI 3009864167 · DUNS 858971074

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • VAIDrug Quality Assurance2023-06-27
  • VAIDrug Quality Assurance2019-11-07
  • VAIDrug Quality Assurance2018-02-23
  • VAIDrug Quality Assurance2015-09-18

Drugs this plant is listed as making

72 distinct drugs across 177 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.